In this study, we applied a proteomics approach to investigate the targets of miR-29b and miR-30c in the secretome of CFs. Most studies rely on bioinformatic algorithms or mRNA analysis for the identification of direct targets. These algorithms are based on an incomplete understanding of miRNA-mRNA seed pairing and evolutionary conservation of miRNAs. 9 They typically predict hundreds to thousands of target genes for 1 miRNA, but with limited overlap, and even the most sensitive programs fail to identify known targets. 10 Importantly, cell type context is not taken into consideration. The utilization of -omics methods is essential for a more comprehensive understanding of miRNA-mediated regulation of gene expression. miRNAs function as posttranscriptional regulators of gene expression, either by inducing mRNA degradation or by blocking protein translation. A systems biology approach aiming at a global readout at the protein rather than the mRNA level may advance our insight into the coordinated regulation of direct as well as indirect targets driving cardiovascular phenotypes after miRNA manipulation. 3 
Methods
An expanded Materials and Methods section is available in the Online Data Supplement. Key techniques involved adaptations of previously published protocols, including those for miRNA measurements [11] [12] [13] and liquid chromatography tandem mass spectrometry. 14, 15 For animal studies, procedures were performed in accordance with the Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 (United Kingdom).
Results

ECM Secretion by CFs
Primary murine CFs were transfected with pre-/anti-miRs of miR-29b or miR-30c (Online Figure I) , and their secretome was analyzed by proteomics (Online Figure II) . Gene ontology (GO) term enrichment confirmed that the majority of proteins identified belong to the extracellular region ( Figure 1A) , including low abundant proteins such as secreted proteases, protease inhibitors, growth factors, and cytokines ( Figure 1B ). Online Table I 
Effects of miR-29b and miR-30c
Both miR-29b and miR-30c are abundant miRNAs in CFs ( Figure 1C ). Based on 3 different algorithms (TargetScan, PicTar, and Diana-microT), fewer common targets were predicted for miR-29b than miR-30c ( Figure 1D ). Yet, pre-miR-29b markedly attenuated protein secretion by CFs, whereas pre-miR-30c had comparably little effect (Figure 2A ). In general, transfection with pre-miRs led to more pronounced protein changes than anti-miRs. In agreement with previous studies, [16] [17] [18] [19] pre-miR-29b reduced collagen (CO1A1, CO5A2) and matrix metalloproteinase-2 secretion ( Figure 2B ). Inhibition by anti-miR-29b also reduced the expression of other miR-29 family members (Online Figure I ) but did not further stimulate collagen and matrix metalloproteinase secretion in cultured CFs.
Proteomics for miRNA Target Identification
To reveal predicted and novel targets of miR-29b and miR-30c, the normalized spectral counts of all extracellular proteins are presented in Online Tables II and III . Besides conventional methods of statistical inference to detect differences in expression, we used a hierarchical Bayes estimation of generalized linear mixed effects model (Qspec). The false discovery rate was calculated with a mixture model-based method of local false discovery rate control based on the Bayes factors. Proteins with a Bayes factor >10, false discovery rate <5%, and a fold change >30% were considered to be significant. Regarding miR-30c, little is known about its extracellular targets. Recently, miR-30c has been shown to target plasminogen activator inhibitor-1. 20 On transfection with pre-miR-30c, plasminogen activator inhibitor-1 was decreased by 25% but fell short of statistical significance in our analysis (Bayes factor=7; Online Table III ). Instead, protein-lysine 6-oxidase, responsible for the cross-linking of peptidyl lysine residues in precursors to fibrous collagen and elastin, displayed a significant reduction in CFs transfected with pre-miR-30c. It was only predicted as a direct target by 1 of the 3 bioinformatics algorithms (Online Figure III) . Results after transfection with pre-miR-29b were much more pronounced (Online Table II , Figure 2C ). Because target derepression can be stress-dependent, the proteomics analysis of pre-miR-29b-transfected CFs was repeated after stimulation with transforming growth factor-β (TGF-β). Among the 186 extracellular proteins identified (Online Table IV ), 92 (≈50%) reached an unadjusted P<0.05 (ANOVA), including 21 of 25 (84%) predicted targets of miR-29b ( Figure 3A ). Again, Qspec was used to detect differential expression. Results are shown in Figure 3B .
Confirmation of Direct and Indirect Targets
The quantification of low abundance proteins by proteomics can be challenging in complex biological samples. Cytokines and growth factors, such as leukemia inhibitory factor (LIF) and insulin-like growth factor 1 (IGF-1), as well as a member of the pentraxin superfamily, pentraxin 3 (PTX-3), showed weak evidence for differential expression (unadjusted P<0.05) in the t test. PTX-3 and LIF had a Bayes factor >4 by Qspec. For independent validation, levels of IGF-1, LIF, and PTX-3 were determined using commercial ELISAs. The ELISA data correlated well to the spectral counts obtained by proteomics in the miR-29b experiment ( Figure 4A -4C; Spearman correlation coefficients, 0.75-0.90). IGF-1 ( Figure 4A ), LIF ( Figure 4B ), and PTX-3 ( Figure 4C ) were suppressed by pre-miR-29b and increased after inhibition by anti-miR-29b. As expected for direct targets, there was complementarity between the miR-29b seed-matching sequence and the 3′-untranslated region (UTR) region of the target mRNAs (LIF, IGF-1, PTX-3; Figure 4D ). To further confirm the functionality of the seed regions of miR-29b, we fused the 3′-UTR of IGF-1, LIF, and PTX-3 to a luciferase reporter vector. Co-expression of synthetic miR-29b decreased IGF-1 and LIF (Online Figure IV) , but not PTX-3 3′-UTR reporter activity (data not shown).
Mimics of miR-29b had the same effect as pre-miR-29b on target gene repression (Online Figure V) . In contrast, miR-30c had no seed-matching sequence in the 3′-UTR of IGF-1, LIF, and PTX-3. Yet, overexpression of miR-30c increased levels of IGF-1 ( Figure 4A ) and LIF ( Figure 4B ). Again, PTX-3 remained unaffected ( Figure 4C ).
In Vivo Validation
Next, adult C57Bl6 mice were treated with antagomiRs directed against miR-29b (3 consecutive intraperitoneal injections at a dose of 80 mg/kg per day; Figure 4E ). On day 7, successful inhibition of cardiac miR-29b was confirmed by quantitative polymerase chain reaction ( Figure 4F ). When we evaluated cardiac mRNA expression, IGF-1 levels were increased by ≈50% compared with respective controls ( Figure 4G ). In plasma, levels of IGF-1 increased by ≈25% ( Figure 4H ), confirming IGF-1 as a target of miR-29b in vitro and in vivo. Neither LIF nor PTX-3 showed significant changes in unstressed hearts or in plasma after antagomiR-29b treatment (data not shown).
Effects on Cell Adhesion
To investigate whether miRNA-induced changes in the secretome of CF impact on cardiac myocyte adhesion, neonatal rat ventricular myocytes (NRVMs) were cultured overnight on glass coverslips precoated with conditioned medium of CFs previously transfected with pre-miR-29b ( Figure 5A ) or anti-miR-29b ( Figure 5B ). Cardiac myocytes were stained for cardiac myosin-binding protein C (green) and cardiac αactinin (red). Nuclei were counterstained with DAPI (blue). Transfection with pre-miR-29b markedly reduced the ability of the conditioned medium from CFs to support adhesion of NRVM ( Figure 5A , Online Figure VI ). The effect of pre-miR-30c on NRVM adhesion was less pronounced. Only when untransfected CFs were seeded on plates precoated with conditioned medium of transfected CFs did pre-miR-29b and anti-miR-29b result in significant changes in early adhesion (Online Figure VII) .
Effects on Cardiac Myocytes
Bidirectional cross-talk between CFs and cardiac myocytes is able to regulate the CF and cardiac myocyte phenotype. 4 NRVM cultured on plastic dishes precoated with conditioned medium of CFs previously transfected with pre-miR-29b displayed reduced expression of α-actinin, cardiac myosinbinding protein C, and cardiac troponin I, as demonstrated by immunoblotting ( Figure 5A ). These cardiac markers were unaltered by anti-miR-29b or pre-miR-30c. In contrast, precoating with conditioned medium from CFs transfected with anti-miR-30c reduced α-actinin and cardiac troponin I expression in NRVM ( Figure 5B) . No difference was observed for cardiac myosin-binding protein C. To test whether the secretomes of transfected CFs have a direct activity on cardiomyocytes, specifically on cardiomyocyte size, we exposed a pure (>95%) cardiomyocyte preparation derived from mouse embryonic stem cells modified to express a neomycin resistance under the cardiomyocyte-restricted α-myosin heavy chain promoter to conditioned medium from pre-miR-29-transfected CF and pre-miR-30c-transfected CF. Under these conditions, cardiomyocytes atrophied (pre-miR-29 conditioned medium) or conversely showed hypertrophic growth (pre-miR-30c conditioned medium; Figure 5C ). Conditioned media from CFs transfected with anti-miRs did not alter cardiomyocyte size.
Cross-Talk Between miRNAs
Our observation that miR-30c and miR-29b induced opposite effects in several experiments ( Figures 4A-4C and 5A-5C) prompted us to investigate the possibility of a cross-talk between miR-30c and miR-29b in CFs. Overexpression of pre-miR-29b was sufficient to reduce the endogenous levels of miR-30c in CFs to a similar extent (≈50%) as TGF-β stimulation of CFs (Online Figure VIII ). Even at a moderate level of miR-29b overexpression (≈20-fold), the difference in miR-30c remained statistically significant, whereas many other miRNAs were not affected (data not shown). 
miR-29b in Cardiac Hypertrophy
Attenuation of miR-29b expression has previously been linked to ECM remodeling after myocardial infarction. 16 miR-29c has also been reported as downregulated in cardiac hypertrophy. 21 Thus, we sought to explore whether endogenous miR-29b and miR-30c levels are affected in mouse models of pathological (transverse aortic constriction [TAC]) and physiological (free running exercise) left ventricular hypertrophy (LVH). RNA was isolated from 23 left ventricular samples (sham: n=6; TAC: n=6; sedentary: n=6; exercise: n=5). TaqMan quantitative polymerase chain reaction revealed a significant decrease of miR-29a, miR-29c, and miR-30c, but not of miR-29b in pathological LVH ( Figure 6A ). Physiological LVH was not associated with significant alterations in any of the miRNAs tested ( Figure 6A ). Yet, miR-29b was abundant in nonmyocytes ( Figure 6B ) and putative miR-29 targets were differentially expressed after TAC ( Figure 6C ).
In Vivo Silencing of miR-29b
To establish whether miR-29b can alter ECM protein expression in pathological hypertrophy, antagomiRs to miR-29b were injected in male C57/Bl6 mice 3 consecutive days before TAC. Hearts were obtained 14 days after surgery. AntagomiR treatment exhibited a marked repression of miR-29b without significant attenuation of other miR-29 family members ( Figure 7A ). Inhibition of miR-29b did not affect cardiac volumes or cardiac function, and overall regional wall hypertrophy remained concentric (Online Table V ). Only in mice with the most pronounced inhibition of miR-29b was the posterior papillary muscle occasionally more echobright and its base thickened (Online Figure IX) . Histologically, excess perivascular fibrosis was observed ( Figure 7B ). Of note, miR-29b inhibition by antagomiRs emerged as a significant determinant of myocardial expression for many direct and indirect targets identified by proteomics, including LIF and IGF-1 ( Figure 7C ). Detailed expression data after TAC are presented in Online Figure X .
Discussion
The molecular mechanisms underlying cardiac fibrosis are of intense interest. miR-29b and miR-30c are 2 key miR-NAs that are enriched in CFs and involved in cardiac fibrosis. In the present study, we applied a proteomics approach to identify extracellular targets of miR-29b and miR-30c. miR-29b had a much stronger effect on the extracellular proteome of CFs than miR-30c and also blocked the response of CFs to TGF-β, one of the master regulators of fibrosis. Besides its major effect on ECM proteins, miR-29b additionally altered the secretion of growth factors and cytokines, such as LIF and IGF-1. In contrast, miR-30c regulated fewer ECM proteins but indirectly modulated the expression of LIF and IGF-1. 
Secretome of Mouse CFs
Few large-scale proteomics studies focusing on the secretome of fibroblasts have been performed so far. 22 Most studies investigated the secretome of feeder cells such as mouse embryonic fibroblasts, which support the growth of embryonic stem cells [23] [24] [25] [26] or dermal fibroblasts. 27, 28 Thus far, only 1 study used CFs and profiled 24 cytokines/chemokines in their conditioned medium. 29 No detailed proteomics analysis has been performed to date. The recognition that cardiac fibrosis is a prominent contributor to myocardial disease and that CFs interact with cardiac myocytes via paracrine mechanisms, alterations in matrix homeostasis, and direct cell-cell interactions have resulted in a growing interest in CFs during the recent years. 4 For example, ECM promotes efficient cardiac differentiation of human pluripotent stem cells. 30 To the best of our knowledge, our proteomic study presents the most extensive characterization of the CF secretome published to date. Among the 245 proteins identified are important proteins for ECM-receptor interaction, focal adhesion, the TGF-β signaling pathway, and cytokine-cytokine receptor interaction. Similar to our recent study of ECM remodeling in a porcine model of cardiac ischemia/reperfusion, 31 this comprehensive map of the CF secretome will provide an important resource for future investigations into factors involved in CF-cardiac myocyte communication.
Proteomics for miRNA Target Identification
Changes in cardiovascular phenotypes after miRNA manipulation are likely to be the result of multiple interactions. Because miRNAs are fine-tuners of protein expression and because the regulation of their target genes tends to be in the range of 20% to 50%, the secretome offers the distinct advantage that miRNA-induced changes accumulate and become more readily detectable by proteomics. The levels of miR-29b expression in our study are similar to previous publications on CFs. 16 An obvious concern is whether transfection with precursor miRNAs interferes with the cellular processing of noncoding RNAs. To exclude off-target effects, we compared 2 miRNAs, both of which play an important role in CFs and are likely to be processed in a similar manner on transfection, in parallel to respective scrambled miRNA controls. Potential explanations for the more pronounced effect of pre-miRNAs over anti-miRs are as follows. Transfection with miRNA precursors will saturate the available binding sites. This is informative about the maximal effect of a particular miRNA within the proteome but does not imply that the expression of these proteins is under the control of the endogenous miRNA. A tight regulation of expression is required, in particular for proteins that have important functions. Individual miRNAs modulate the expression of several targets, which often are effectors of the same biological process. Conversely, several miRNAs can target the same effector. 1 Diverse miRNAs can also act cooperatively or redundantly to regulate the effectors of the same biological process. Thus, derepression of a protein based on inhibition of a single miRNA is more difficult to achieve. Most transgenic animals for miRNAs have no baseline phenotype but develop a phenotype in response to a stress stimulus. Stress conditions are likely to alter the susceptibility of proteins for the control by endogenous miRNAs. The abundance of the mRNA is as important for miRNA target regulation as the concentration of the endogenous miRNA itself. Thus, proteins that change after the transfection of the precursor but do not change by antagonizing the endogenous miRNA in unstimulated cells or normal hearts could still be affected during a stress response. Currently, miRNA target identification is mainly performed in unstressed cells. Our proteomics analyses were performed at baseline and after TGF-β stimulation. Moreover, confirmation of target repression was obtained using miRNA mimics and antagomiR treatment in a mouse model of pathological LVH.
Role of miR-29b in Cardiac Disease
The miR-29 family is present with 4 copies in the genome and is mainly expressed in fibroblasts. Unlike most miRNAs that are only present in the cytosol, miR-29 is also found in the nucleus. After myocardial infarction, miR-29b is downregulated in the region adjacent to the infarcted area, suggesting a pertinent role of this miRNA in cardiac remodeling. 16 Besides its involvement in the development of cardiac fibrosis, the miR-29 family has been implicated in aortic aneurysm formation 32, 33 and atherosclerosis. 18 Its modulatory effect on ECM protein secretion and potential importance in different cardiovascular diseases has made it a lead miRNA for therapeutic intervention. Thus far, the effect of miR-29b in CFs was mainly assessed at the mRNA level. Overexpression of miR-29b reduced expression of collagens, whereas downregulation of miR-29b with anti-miRs induced the expression of collagens in vitro and in vivo. 16 Our proteomic data confirm that pre-miR-29b is a potent regulator of ECM synthesis. The effect of anti-miR-29b in cultured CF, however, was not as pronounced.
Although we failed to observe a significant change of miR-29b expression in 2 mouse models of LVH, this does not negate a potential role of miR-29b for initial ECM deposition during cardiac hypertrophy because miRNA measurements were only performed at 1 time point (14 days postsurgery or 28 days postexercise). In fact, treatment with antagomiRs to miR-29b increased ECM deposition after aortic constriction. Previous studies with miR-29 inhibition were performed in unstressed hearts, and the expression of 3 collagen transcripts (Col1A1, Col1A2, and Col3A1) was only modestly increased. 16 After TAC, we did observe target derepression and increased perivascular fibrosis in response to miR-29b inhibition.
CF-Cardiac Myocyte Interactions
miRNA levels in CFs may have an impact on cardiac myocytes regarding their adhesive properties and growth characteristics.
Recently, Castoldi et al 17 have demonstrated that miR-133a, a miRNA expressed in cardiac myocytes and involved in cardiac hypertrophy, also targets CO1A1, a target of miR-29b. Their data support the concept that myocardial fibrosis could be modulated not only by miRNAs expressed in CFs but also by muscle-specific miRNAs through a synergistic action on CO1A1 mRNA expression. However, little is known regarding the role of miR-29b in the communication between CFs and cardiac myocytes and its involvement in myocardial hypertrophy. Our data suggest that miR-29b not only regulates ECM protein deposition but also may contribute to development of cardiac hypertrophy by targeting important growth factors and inflammatory mediators, with IGF-1, LIF, and PTX-3 among the potential targets of miR-29b. PTX-3 is a member of the pentraxin superfamily that plays an important role at the interface of inflammation and ECM remodeling. 34, 35 It has been suggested as a novel biomarker of left ventricular dysfunction and heart failure with normal ejection fraction. 35 Interestingly, various inflammatory molecular cascades, in particular Toll-like receptor signaling, stimulate the expression of PTX-3 36 and the promoter region of miR-29b shows ≥4 different binding sites for nuclear factor-kappa B. 37 LIF is a member of the interleukin-6 family that is synthesized by different cell types in the myocardium, including cardiac myocytes and CFs. 38 Previous studies have demonstrated that LIF confers both hypertrophic and cytoprotective responses in adult cardiac myocytes via the gp130 and LIF receptor signaling complex. 39, 40 IGF-1 is a key regulator of growth, survival, and differentiation. In myocardial biology, IGF-1 and its signal transduction cascade are involved in development, cardiac myocyte size and survival, action potential, and excitation-contraction coupling. 41, 42 Interestingly, miR-29b and miR-30c exerted opposite effects on IGF-1 and LIF secretion by CFs and in most functional experiments. This is in agreement with previous reports that miRNAs in the same cell type could regulate the same targets counterbalancing each other. 1 To rule out indirect effects mediated via contaminating stroma cells, we exposed a highly purified cardiomyocyte population derived from embryonic stem cells to conditioned medium and observed that the pre-miR-29b and pre-miR-30c CF secretomes did impart opposite effects on cardiomyocyte growth, that is, atrophy and hypertrophy, respectively. These effects were likely mediated by soluble growth factors, suggesting that the observed paracrine effects on cardiomyocytes may not only be attributable to adhesive ECM molecules.
Conclusion
Our proteomics study provides the most comprehensive characterization of the mouse CF secretome to date. A particular strength is the proteome-wide analysis of miRNA function, which offers unique insight into the regulation of protein networks controlled by miR-29b and miR-30c. Direct and indirect targets were identified from a broader proteomics screen and validated in vivo. Many of these targets would not have been anticipated based on current bioinformatics prediction models. Addressing the complexity of miRNA-regulated gene expression is an essential step to facilitate a better understanding of their concerted actions in cardiac fibrosis. 
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